ソファルコン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/06/25 18:49:07」(JST)
[Wiki en表示]
Sofalcone
|
Systematic (IUPAC) name |
[5-[(3-methylbut-2-en-1-yl)oxy]-2-((2E)-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}prop-2-enoyl)phenoxy]acetic acid |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Legal status
|
|
Routes of
administration
|
Oral |
Identifiers |
CAS Registry Number
|
64506-49-6 Y |
ATC code
|
None |
PubChem |
CID: 5282219 |
ChemSpider |
4445402 N |
UNII |
2B668TJX8E Y |
KEGG |
D01956 Y |
Chemical data |
Formula |
C27H30O6 |
Molecular mass
|
450.52 g/mol |
SMILES
- CC(=CCOC1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)OCC=C(C)C)OCC(=O)O)C
|
InChI
-
InChI=1S/C27H30O6/c1-19(2)13-15-31-22-8-5-21(6-9-22)7-12-25(28)24-11-10-23(32-16-14-20(3)4)17-26(24)33-18-27(29)30/h5-14,17H,15-16,18H2,1-4H3,(H,29,30)/b12-7+ N
Key:GFWRVVCDTLRWPK-KPKJPENVSA-N N
|
N (what is this?) (verify) |
Sofalcone (INN) is an oral gastrointestinal medication. It is a synthetic derivative of sophoradin,[1] a chalconoid, a type of natural phenol found in Sophora tonkinensis (or Sophora subprostrata), a herb used in traditional Chinese medicine.
References
- ^ Konturek SJ, Mrzozowski T, Drozdowicz D, Pawlik W, Sendur R (August 1987). "Gastroprotective and ulcer healing effects of solon, a synthetic flavonoid derivative of sophoradin". Hepatogastroenterology 34 (4): 164–70. PMID 3478294.
Drugs for peptic ulcer and GERD/GORD (A02B)
|
|
H2 antagonists ("-tidine") |
- Cimetidine
- Famotidine
- Lafutidine
- Loxtidine
- Niperotidine
- Nizatidine
- Ranitidine
- Roxatidine
|
|
Prostaglandins (E)/analogues ("-prost-") |
|
|
Proton-pump inhibitors ("-prazole") |
- Dexlansoprazole
- Esomeprazole
- Ilaprazole
- Lansoprazole
- Omeprazole
- Pantoprazole
- Picoprazole
- Rabeprazole
- Tenatoprazole
- Timoprazole
|
|
Potassium-competitive acid blockers ("-prazan") |
- Linaprazan
- Revaprazan
- Soraprazan
- Vonoprazan
|
|
Other |
- Acetoxolone
- Alginic acid
- Arbaclofen placarbil
- Carbenoxolone
- Cetraxate
- Gefarnate
- Lesogaberan
- Pirenzepine
- Proglumide
- Rebamipide
- Sucralfate
- Sulglicotide
- Telenzepine
- Teprenone
- Troxipide
- Zolimidine
|
|
- See also: Helicobacter pylori eradication protocols
|
|
Index of digestion
|
|
Description |
- Anatomy
- Physiology
- Development
|
|
Disease |
- Congenital
- Neoplasms and cancer
- Inflammatory bowel disease
- Gluten sensitivity
- Other
- Symptoms and signs
- Blood tests
|
|
Treatment |
- Procedures
- Drugs
- anabolic steroids
- antacids
- diarrhoea and infection
- bile and liver
- functional gastrointestinal disorders
- laxatives
- peptic ulcer and reflux
- nausea and vomiting
- other
- Surgery
|
|
|
Chalconoids and their glycosides
|
|
Chalconoids |
- Butein
- Isoliquiritigenin
- Methyl hydroxychalcone
- Okanin
|
|
Chalconoid glycosides |
- Carthamin
- Marein
- okanin 3,4,3′-trimethyl ether 4′-glucoside
- okanin 4-methyl ether 4′-glucoside
- okanin 4-methyl ether 4′-glucoside monoacetate
- Okanin 3,4-dimethyl ether 4′-glucoside
|
|
Acylated chalconoids |
- Licochalcone A
- Sophoradin (prenylated)
- Tephrospinosin (3′,5′-diisopentenyl-2′,4′-dihydroxychalcone) (prenylated)
- Xanthohumol (prenylated)
|
|
O-methylated chalconoids |
- Cardamomin
- Flavokawin B
- Okanin 3,4,3′,4′-tetramethyl ether
- Pashanone (2',6'-Dihydroxy-3',4'-dimethoxychalcone)
|
|
Flavokavains |
- Flavokavain A
- Flavokavain B
- Flavokavain C
|
|
Synthetic |
|
|
English Journal
- Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice.
- Onuma W1,2, Tomono S3, Miyamoto S1, Fujii G4, Hamoya T1, Fujimoto K5, Miyoshi N3, Fukai F2, Wakabayashi K3, Mutoh M1,4.
- Oncotarget.Oncotarget.2016 Feb 23;7(8):8640-52. doi: 10.18632/oncotarget.7082.
- This study aimed to identify gastric mucosal protectants that suppress intestinal tumorigenesis in a mouse model. We chose six gastric mucosal protectants (ecabet sodium hydrate, irsogladine maleate, rebamipide, sofalcone, teprenone and troxipide) and examined their effects on the activity of oxidat
- PMID 26840084
- Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
- Onda K1, Tong S1, Nakahara A1, Kondo M1, Monchusho H1, Hirano T1, Kaitu'u-Lino T1, Beard S1, Binder N1, Tuohey L1, Brownfoot F1, Hannan NJ2.
- Hypertension (Dallas, Tex. : 1979).Hypertension.2015 Apr;65(4):855-62. doi: 10.1161/HYPERTENSIONAHA.114.04781. Epub 2015 Feb 9.
- Preeclampsia is a severe complication of pregnancy, characterized by hypertension, oxidative stress, and severe endothelial dysfunction. Antiangiogenic factors, soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin, play key pathophysiological roles in preeclampsia. Heme oxygenase-1 (HO-1
- PMID 25667213
- "Gastric cytoprotection" is still relevant.
- Szabo S1.
- Journal of gastroenterology and hepatology.J Gastroenterol Hepatol.2014 Dec;29 Suppl 4:124-32. doi: 10.1111/jgh.12735.
- Although Andre Robert's historic article on "gastric cytoprotection" in 1979 introduced this new name and concept, gastroprotective drugs (e.g. sofalcone, sucralfate), which prevent and/or accelerate healing of gastric ulcers without inhibiting acid secretion, were known in Japan before or around th
- PMID 25521744
Japanese Journal
- Influence of Aging on Gastric Cytoprotective and Ulcer Healing Activities of Sofalcone
- ISHIHARA Masashi,KOJIMA Ryoji,ITO Mikio
- 応用薬理 80(5), 71-77, 2011-08-10
- NAID 10029468235
- P1-503 消化性潰瘍治療薬sofalconeは脂肪細胞とマクロファージの炎症性相互作用を改善し脂肪前駆細胞の分化を抑制する(一般演題 ポスター発表,薬物療法(その他),医療薬学の創る未来 科学と臨床の融合)
- Analysis of sofalcone in human plasma by high performance liquid chromatography
- WEN Aidong,WANG Zhipeng,HANG Taijun,JIA Yanyan,ZHANG Tingting,WU Yin,GAO Xuan,YANG Zhifu
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 856(1), 348-352, 2007-09-01
- NAID 10025808252
Related Pictures
★リンクテーブル★
[★]
- 英
- sofalcone
- 商
- スコーウエ、セスファルコ、ソルドロン、ソロン、トファルコン、パランコン、ラビン
- 関
- 消化性潰瘍用剤